Search results
Meet The International Megacaps That 'Match Or Surpass' Magnificent Seven Stocks
Investor's Business Daily· 3 days agoInternational stocks, at large, are perking up in 2024. Novo Nordisk, ASML Holding, AstraZeneca, SAP...
Why many people with lung cancer who have never smoked don't respond well to treatments
MedicalNewsToday via AOL· 22 hours agoResearchers have honed in on two genetic mutations they say may be responsible for the...
Lung Cancer Screening Rates Remain Low in the U.S., Especially in the South
MedPage Today· 4 days agoFewer than one in five people eligible for lung cancer screening reported being up to date with screening in 2022, though patient navigation added to usual care could be a way of increasing ...
Nanoliposomal Irinotecan Fails to Boost Survival in Treated Advanced Biliary Cancer
MedPage Today· 2 days agoNo difference in PFS, median OS favored control group
Most CEOs are defeating attempts to vote down their pay. Can Tesla's Elon Musk do the same?
Yahoo Finance· 4 days agoMost bosses are defeating shareholder attempts so far this year to tamp down their pay. The question...
Radiopharmaceuticals Are A Buzzy Area For Deal-Making
Crunchbase· 20 hours agoWhen reporting on startup investment, big funding rounds and M&A deals for pharmaceutical companies...
Oncologists Voice Financial Concerns of Genomic Testing
Medscape· 1 day agoDr Maurie Markman discusses genomic testing and the associated financial considerations.
Mutation Mystery Solved: Why Lung Cancer Treatments Often Fail in Non-Smokers
SciTechDaily· 22 hours agoConducted by researchers from UCL, the Francis Crick Institute, and AstraZeneca, the study is...
Factbox-Battles over CEO pay across the globe By Reuters
Investing.com· 1 day agoMusk said late on Wednesday that shareholders were voting by wide margins to approve the pay...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
Fox News· 3 days agoA combination COVID-influenza vaccine is apparently one step closer to hitting the market. Moderna,...